Affinage

BBS1

BBSome complex member BBS1 · UniProt Q8NFJ9

Length
593 aa
Mass
65.1 kDa
Annotated
2026-04-28
38 papers in source corpus 12 papers cited in narrative 13 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

BBS1 is a core subunit of the BBSome, an octameric ciliary trafficking complex, and is the most commonly mutated gene in Bardet-Biedl syndrome (PMID:12118255). BBS1 mediates the translocation of the assembled BBSome from pericentriolar satellites to the ciliary base, where it facilitates ARL6/BBS3-dependent membrane recruitment and retrograde trafficking of ciliary GPCRs such as Smoothened and GPR161 (PMID:29590217, PMID:32759308). Loss of BBS1 destabilizes the BBSome complex, causing accumulation of membrane-associated proteins and cholesterol in photoreceptor outer segments leading to early visual dysfunction, and disrupts epithelial identity by failing to suppress epithelial-to-mesenchymal transition in renal and other cell types (PMID:35277505, PMID:37998397). Beyond ciliary functions, BBS1 promotes centrosome polarization toward the T cell immune synapse by coupling the 19S proteasome to dynein for centrosomal F-actin clearance, and T cell-specific Bbs1 deletion impairs CD4 T cell-mediated wound healing (PMID:34423835, PMID:36534590).

Mechanistic history

Synthesis pass · year-by-year structured walk · 8 steps
  1. 2002 High

    Identifying BBS1 as the most frequently mutated gene in Bardet-Biedl syndrome established it as a central locus in ciliopathy pathogenesis and showed that a single missense variant (M390R) accounts for most BBS1 disease alleles.

    Evidence Positional cloning and mutational analysis in BBS families

    PMID:12118255

    Open questions at the time
    • Protein function unknown
    • Subcellular localization undetermined
    • No interacting partners identified
  2. 2003 High

    Demonstrating that BBS1 genetically interacts with all other known BBS loci in oligogenic inheritance patterns, and that disease-causing mutations mislocalize the protein, established that BBS proteins operate in a shared functional pathway requiring correct subcellular targeting.

    Evidence Genetic epistasis analysis across 259 BBS families; fluorescence microscopy of mutant vs. wild-type BBS1 in transfected mammalian cells

    PMID:12677556 PMID:12837689

    Open questions at the time
    • Biochemical nature of the shared pathway unknown
    • Direct physical interactions among BBS proteins not yet shown
    • Ciliary relevance not established
  3. 2018 High

    BBS1 knockout revealed its essential role in retrograde trafficking of ciliary GPCRs (Smoothened, GPR161) and showed that BBS1 is required for ciliary entry of other BBSome subunits and ARL6, with the ARL6-BBS1 interaction reinforced by BBS9, defining BBS1 as central to BBSome assembly and ARL6-mediated membrane recruitment.

    Evidence BBS1 KO cell lines with rescue by wild-type vs. BBS9-binding-deficient BBS1; immunofluorescence for ciliary GPCRs; Co-IP for ARL6-BBS1-BBS9 interaction

    PMID:29590217

    Open questions at the time
    • Structural basis of BBS1-ARL6-BBS9 ternary interaction not resolved
    • Whether BBS1 directly contacts cargo GPCRs or acts through adaptor proteins unknown
  4. 2020 High

    Establishing that BBSome assembly is sequential — with BBS4 nucleating a pre-BBSome at pericentriolar satellites and BBS1 then mediating translocation to the ciliary base — resolved the spatiotemporal order of complex biogenesis and assigned BBS1 a specific post-assembly trafficking role.

    Evidence Fluorescently tagged BBSome subunits in individual KO cell lines; FRAP, FCS, expansion microscopy, biochemical fractionation

    PMID:32759308

    Open questions at the time
    • Motor or transport machinery used by BBS1 for satellite-to-ciliary-base translocation not identified
    • Whether BBS1 acts catalytically or as a structural scaffold for translocation unknown
  5. 2021 Medium

    Discovery that BBS1 promotes centrosome polarization toward the T cell immune synapse by coupling the 19S proteasome regulatory subunit to dynein for centrosomal F-actin and WASH1 clearance revealed a non-ciliary, proteasome-dependent function for BBS1.

    Evidence BBS1 knockdown/knockout in T cells; Co-IP for BBS1-dynein-19S proteasome; immunofluorescence; proteasome inhibitor experiments

    PMID:34423835

    Open questions at the time
    • Single lab finding; independent replication pending
    • Whether this function requires the intact BBSome or BBS1 alone not established
    • Structural basis for BBS1-dynein-proteasome coupling unknown
  6. 2022 High

    Bbs1 loss in zebrafish photoreceptors demonstrated that BBS1 maintains BBSome stability and outer segment lipid homeostasis — particularly cholesterol levels — with functional visual deficits preceding structural degeneration, providing a molecular link between ciliary trafficking defects and retinal disease.

    Evidence bbs1 zebrafish mutant; quantitative proteomics and lipidomics on outer segments; electroretinography

    PMID:35277505

    Open questions at the time
    • Whether cholesterol accumulation is a direct consequence of impaired lipid transporter trafficking or secondary metabolic dysregulation not resolved
    • Mechanism of BBS1-dependent lipid homeostasis not defined
  7. 2022 Medium

    T cell-specific Bbs1 deletion impaired CD4 T cell-mediated wound closure and altered CD4/CD8 ratios under inflammatory stimulation, extending BBS1 function to adaptive immune regulation in vivo.

    Evidence Conditional Bbs1 KO mice; flow cytometry; wound closure and Imiquimod treatment models

    PMID:36534590

    Open questions at the time
    • Whether immune phenotype is cilium-dependent or reflects the non-ciliary BBS1 function in T cells not determined
    • Mechanism linking BBS1 loss to altered CD4/CD8 ratios unknown
  8. 2023 Medium

    BBS1 loss in renal collecting duct cells caused failure to suppress mesenchymal gene programs during differentiation, with EMT gene dysregulation confirmed across BBS mutant mouse hypothalamus and patient fibroblasts, establishing EMT suppression as a general BBS1-dependent process across tissues.

    Evidence CRISPR Bbs1 KO IMCD3 lines; transcriptomics across cell lines, mouse tissue, and patient fibroblasts

    PMID:37998397

    Open questions at the time
    • Direct mechanism by which BBS1/BBSome suppresses EMT unknown
    • Whether EMT phenotype is cilium-dependent or reflects altered receptor trafficking not distinguished

Open questions

Synthesis pass · forward-looking unresolved questions
  • Key unresolved questions include the structural basis of BBS1 within the BBSome at atomic resolution during cargo engagement, the motor/adaptor machinery by which BBS1 drives satellite-to-ciliary-base translocation, and the extent to which BBS1's non-ciliary functions (immune synapse polarization, EMT regulation, TGFBR1 recycling) are BBSome-dependent versus independent.
  • No high-resolution structure of BBS1 in complex with ARL6 and cargo
  • Motor driving BBS1-mediated translocation from satellites to ciliary base unidentified
  • Cilium-dependent vs. cilium-independent functions not genetically separated

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060090 molecular adaptor activity 3
Localization
GO:0005815 microtubule organizing center 2 GO:0005929 cilium 2
Pathway
R-HSA-162582 Signal Transduction 3 R-HSA-168256 Immune System 2 R-HSA-1852241 Organelle biogenesis and maintenance 2 R-HSA-5653656 Vesicle-mediated transport 2
Complex memberships
BBSome

Evidence

Reading pass · 13 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2002 BBS1 was identified as the gene most commonly mutated in Bardet-Biedl syndrome, with a missense mutation (M390R) accounting for the majority of BBS1 cases; the gene product was shown to be highly conserved between mice and humans. Positional cloning, mutational analysis, sequence conservation analysis Nature genetics High 12118255
2003 BBS1 shares structural features (a conserved functional domain) with BBS2 and BBS7, suggesting these three proteins participate in a common functional pathway relevant to BBS pathogenesis. Phylogenetic and genomic comparative analysis, motif-based identification American journal of human genetics Low 12567324
2003 Introduction of a BBS1 missense mutation into mammalian cells causes dramatic mislocalization of the BBS1 protein compared to wild-type, indicating the mutation disrupts normal subcellular targeting. Transfection of mutant BBS1 constructs into mammalian cells, fluorescence microscopy for localization Human molecular genetics Medium 12837689
2003 BBS1 participates in oligogenic/non-Mendelian inheritance, genetically interacting with mutations at each of the other known BBS loci (BBS2, BBS4, BBS6, BBS7) to cause or modulate disease, demonstrating functional genetic interactions among BBS proteins. Genetic epistasis analysis, mutational screening of 259 BBS families, statistical modeling American journal of human genetics High 12677556
2018 BBS1 is required for retrograde trafficking of ciliary GPCRs (Smoothened and GPR161) out of cilia; BBS1 knockout cells show defects in ciliary entry of other BBSome subunits (BBS2, BBS7, BBS9) and ARL6, and the trafficking defect is rescued by wild-type BBS1 but not by a BBS9-binding-deficient BBS1 mutant. The ARL6/BBS3-BBS1 interaction is reinforced by BBS9, indicating BBS1 is central to BBSome assembly and ARL6-mediated membrane recruitment. BBS1 knockout cell lines, rescue with wild-type vs. mutant BBS1, immunofluorescence microscopy for ciliary GPCR localization, Co-IP for ARL6-BBS1-BBS9 interaction PloS one High 29590217
2020 BBSome assembly is a sequential process in which BBS4 nucleates a pre-BBSome at pericentriolar satellites, followed by BBS1-mediated translocation of the assembled BBSome to the ciliary base. BBS1 is required for the ciliary base localization step of BBSome biogenesis. Library of human cell lines deficient in individual BBSome subunits expressing fluorescently tagged subunits; biochemical fractionation, FRAP, fluorescence correlation spectroscopy, expansion microscopy The Journal of biological chemistry High 32759308
2021 BBS1 controls centrosome polarization toward the immune synapse in T cells by promoting clearance of centrosomal F-actin and its regulator WASH1 via proteasome-dependent degradation, coupling the 19S proteasome regulatory subunit to the microtubule motor dynein for transport to the centrosome. BBS1 knockdown/knockout in T cells, immunofluorescence for centrosome position and F-actin, Co-IP for BBS1-dynein-19S proteasome interactions, proteasome inhibitor experiments Journal of cell science Medium 34423835
2022 Bbs1 loss in zebrafish disrupts BBSome complex stability and leads to accumulation of membrane-associated proteins (particularly those involved in lipid homeostasis) in photoreceptor outer segments, resulting in elevated outer segment cholesterol content and early visual deficits preceding structural degeneration. bbs1 zebrafish mutant; quantitative proteomics and lipidomics on isolated outer segment-enriched samples; electroretinography for functional assessment Nature communications High 35277505
2021 Ectopic expression of wild-type human BBS1 driven by the CAG promoter rescues male infertility (spermatozoa flagella assembly) but not retinal degeneration in Bbs1-M390R knock-in mice, indicating tissue-specific requirements for BBS1 expression levels. Transgenic mouse cross onto Bbs1M390R/M390R background; fertility testing; electroretinography; optical coherence tomography; immunohistochemistry; qRT-PCR for tissue expression Gene therapy Medium 33664503
2022 T cell-specific deletion of Bbs1 impairs CD4 T cell-mediated skin wound closure and alters splenic CD4/CD8 ratios upon Imiquimod stimulation, demonstrating a functional role for BBS1/BBSome in selective T cell immune responses. T cell-specific Bbs1 conditional knockout mice; flow cytometry; wound closure assay; Imiquimod treatment model American journal of physiology. Regulatory, integrative and comparative physiology Medium 36534590
2023 BBS1 loss in renal collecting duct IMCD3 cells leads to failure to suppress mesenchymal cell identities (epithelial-to-mesenchymal transition) as cells differentiate, associated with loss of epithelial markers and tight junction formation; transcriptomic analysis of BBS mutant mouse hypothalamus and BBS patient fibroblasts confirms dysregulation of EMT genes as a general feature across tissues. CRISPR-edited clonal IMCD3 Bbs1 KO cell lines; phenotypic screen; multi-omics (transcriptomics); analysis of mouse hypothalamic preparations and patient fibroblasts Cells Medium 37998397
2025 BBS1 knockout leads to altered phosphorylation of TGF-β pathway components; network analysis identifies CDK2 as a central kinase in the BBS1 KO interactome, implicating BBS1 in regulation of TGF-β signaling and extracellular matrix regulation. CRISPR-CAS9 BBS1 KO; phosphoproteomics; network diffusion analysis; protein interaction mapping Scientific reports Low 41193622
2024 BBS1 knockout in retinal epithelial cells causes delayed transferrin internalization and increased recycling of TGFBR1 (rather than degradation), promoting EMT with increased cell migration and reduced proliferation after TGF-β stimulation; this contrasts with BBS4 KO which promotes receptor degradation, indicating BBS1 specifically regulates the recycling arm of receptor endocytic trafficking. BBS1 KO cell lines; transferrin uptake assay; TGFBR1 recycling vs. degradation assay; EMT marker analysis; migration and proliferation assays bioRxivpreprint Low

Source papers

Stage 0 corpus · 38 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2002 Identification of the gene (BBS1) most commonly involved in Bardet-Biedl syndrome, a complex human obesity syndrome. Nature genetics 267 12118255
2003 Genetic interaction of BBS1 mutations with alleles at other BBS loci can result in non-Mendelian Bardet-Biedl syndrome. American journal of human genetics 196 12677556
2003 Identification of a novel Bardet-Biedl syndrome protein, BBS7, that shares structural features with BBS1 and BBS2. American journal of human genetics 172 12567324
2003 Heterozygous mutations in BBS1, BBS2 and BBS6 have a potential epistatic effect on Bardet-Biedl patients with two mutations at a second BBS locus. Human molecular genetics 153 12837689
2012 BBS1 mutations in a wide spectrum of phenotypes ranging from nonsyndromic retinitis pigmentosa to Bardet-Biedl syndrome. Archives of ophthalmology (Chicago, Ill. : 1960) 102 23143442
2003 Evaluation of complex inheritance involving the most common Bardet-Biedl syndrome locus (BBS1). American journal of human genetics 92 12524598
2006 Retinal disease expression in Bardet-Biedl syndrome-1 (BBS1) is a spectrum from maculopathy to retina-wide degeneration. Investigative ophthalmology & visual science 66 17065520
2018 BBS1 is involved in retrograde trafficking of ciliary GPCRs in the context of the BBSome complex. PloS one 54 29590217
2008 A novel founder BBS1 mutation explains a unique high prevalence of Bardet-Biedl syndrome in the Faroe Islands. The British journal of ophthalmology 47 18669544
1999 Delineation of the critical interval of Bardet-Biedl syndrome 1 (BBS1) to a small region of 11q13, through linkage and haplotype analysis of 91 pedigrees. American journal of human genetics 40 10577921
2015 Targeted multi-gene panel testing for the diagnosis of Bardet Biedl syndrome: Identification of nine novel mutations across BBS1, BBS2, BBS4, BBS7, BBS9, BBS10 genes. European journal of medical genetics 39 26518167
1999 A founder effect in the newfoundland population reduces the Bardet-Biedl syndrome I (BBS1) interval to 1 cM. American journal of human genetics 37 10577922
2012 Phenotypic expression of Bardet-Biedl syndrome in patients homozygous for the common M390R mutation in the BBS1 gene. Vision research 36 22940089
2013 Exome sequencing identifies a novel and a recurrent BBS1 mutation in Pakistani families with Bardet-Biedl syndrome. Molecular vision 29 23559858
2022 Loss of the Bardet-Biedl protein Bbs1 alters photoreceptor outer segment protein and lipid composition. Nature communications 25 35277505
2020 The BBSome assembly is spatially controlled by BBS1 and BBS4 in human cells. The Journal of biological chemistry 23 32759308
2021 BBS1 branchpoint variant is associated with non-syndromic retinitis pigmentosa. Journal of medical genetics 21 33910932
2020 A BBS1 SVA F retrotransposon insertion is a frequent cause of Bardet-Biedl syndrome. Clinical genetics 21 33169370
2019 Combining Engineered U1 snRNA and Antisense Oligonucleotides to Improve the Treatment of a BBS1 Splice Site Mutation. Molecular therapy. Nucleic acids 19 31541798
2014 Novel RP1 mutations and a recurrent BBS1 variant explain the co-existence of two distinct retinal phenotypes in the same pedigree. BMC genetics 19 25494902
2013 The Leishmania major BBSome subunit BBS1 is essential for parasite virulence in the mammalian host. Molecular microbiology 17 23998526
1999 Evaluation and molecular characterization of EHD1, a candidate gene for Bardet-Biedl syndrome 1 (BBS1). Gene 15 10564830
2021 The Bardet-Biedl syndrome complex component BBS1 controls T cell polarity during immune synapse assembly. Journal of cell science 14 34423835
2008 Bardet-biedl syndrome: an atypical phenotype in brothers with a proven BBS1 mutation. Ophthalmic genetics 14 18766993
1998 A transcript map of an 800-kb region on human chromosome 11q13, part of the candidate region for SCA5 and BBS1. Human genetics 9 9921902
2021 Ectopic expression of BBS1 rescues male infertility, but not retinal degeneration, in a BBS1 mouse model. Gene therapy 4 33664503
2020 Novel biallelic splice-site BBS1 variants in Bardet-Biedle syndrome: a case report of the first Japanese patient. Documenta ophthalmologica. Advances in ophthalmology 4 31997113
2022 Case Report: Identification Pathogenic Abnormal Splicing of BBS1 Causing Bardet-Biedl Syndrome Type I (BBS1) due to Missense Mutation. Frontiers in genetics 3 35692835
2021 Retinitis Pigmentosa and Polydactyly in a Patient with a Heterozygous Mutation on the BBS1 Gene. International medical case reports journal 3 34262361
2022 T cell-specific deficiency in BBSome component BBS1 interferes with selective immune responses. American journal of physiology. Regulatory, integrative and comparative physiology 2 36534590
2024 Novel BBS1 deletion and BBS9 nonsense pathogenic variant in Bardet-Biedl syndrome. Ophthalmic genetics 1 39618083
2023 De-Suppression of Mesenchymal Cell Identities and Variable Phenotypic Outcomes Associated with Knockout of Bbs1. Cells 1 37998397
2022 Lethal neonatal respiratory failure due to biallelic variants in BBS1 and monoallelic variant in TTC21B. Pediatric nephrology (Berlin, Germany) 1 35695966
2018 Generation of induced pluripotent stem cells, KCi001-A derived from a Bardet-Biedl syndrome patient compound heterozygous for the BBS1 variants c.1169T>G/c.1135G>C. Stem cell research 1 30142598
2026 Genetic and Phenotypic Characterization of a Large Cohort of Patients with BBS1-Retinopathy. Ophthalmology science 0 42022048
2025 Genomic Analysis for the Safety Assessment of a Potential Probiotic Strain Pediococcus pentosaceus BBS1 Isolated From Lao Fermented Bamboo Shoots (Nor Mai Som). MicrobiologyOpen 0 40923755
2025 Phosphoproteomic profiling highlights CDC42 and CDK2 as key players in the regulation of the TGF-β pathway in ALMS1 and BBS1 knockout models. Scientific reports 0 41193622
2021 Compound Heterozygous Mutations in the BBS-1 Gene and its Clinical Presentation: A Case Report. Puerto Rico health sciences journal 0 34792930